Drug Discovery
Boltz-2: The New Benchmark for AI-Driven Binding Affinity Prediction in Drug Discovery
Boltz-2, an open-source AI model from MIT and Recursion, unifies structural and energetic prediction, delivering near-FEP accuracy in seconds and redefining molecular screening workflows.